Biotech · updated daily

Biotech companies hiring now

125 biotech companies are hiring right now, with 3,836 open roles on their own career pages: drug discovery, AI for biology and life-science tools. They opened 490 new roles in the last 7 days. The biggest hirers: AbbVie, Amgen, Bms.

AbbVie

AbbVie

North Chicago, US · Post Ipo

The company focuses on therapy areas including rheumatology, dermatology, gastroenterology, oncology, neuroscience, eye care, aesthetics, and infectious diseases.

1,336 open roles+380 this week

Amgen

Amgen

Thousand Oaks, US · Post Ipo

Amgen is a biotechnology company that develops medicines and related healthcare products.

1,237 open roles+10 this week

Bms

Bms

Princeton, US · Post Ipo

Bristol Myers Squibb develops medicines and other biopharmaceutical products for healthcare markets.

318 open roleshiring

Tempus Labs

Tempus Labs

Chicago, US · Post Ipo

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. Its proprietary platform connects real-world evidence to deliver real-time, actionable insights to physicians for personalized patient care.

103 open roleshiring

Benchling

Benchling

San Francisco, US · Series F

Benchling is the AI platform for biotech R&D. Scientists use Benchling to design experiments, capture structured data, and run AI agents and models directly in their workflows. Over 200,000 scientists around the world trust Benchling to power their most important work, from academic labs to Sanofi, Moderna, and more than half of the world's top 50 biopharma.

58 open roles+8 this week

Precision for Medicine

Precision for Medicine

Precision for Medicine is a biomarker-driven clinical research and development services organization for life sciences companies. Its approach integrates clinical trial design and execution with scientific knowledge, laboratory expertise and data intelligence. It runs a CRO with oncology and rare disease expertise. It also offers translational and biomarker laboratory services with global clinical logistics.

47 open roles+15 this week

Twist Bioscience

Twist Bioscience

South San Francisco, US · Post Ipo

The company developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a high-throughput silicon platform.

43 open roles+7 this week

Oxford Nanopore

Oxford Nanopore

Oxford Nanopore provides devices for DNA and RNA sequencing. Its MinKNOW software records sequencing signals and controls the devices.

37 open roles+3 this week

Schrödinger

Schrödinger

New York, US

Schrödinger offers a computational platform for discovering novel, optimized molecules for drug development and materials design. The platform uses the physics of molecular interactions, accelerated by machine learning, to simulate and predict properties of novel molecules. Its software is licensed by biotechnology, pharmaceutical and industrial companies and academic institutions.

35 open roles+1 this week

Alamar Biosciences

Alamar Biosciences

Alamar Biosciences provides a platform to detect biomarkers with ultra-high sensitivity. The platform helps researchers examine protein biomarkers across disease states.

26 open roles+2 this week

Arc Institute

Arc Institute

Palo Alto, US

Arc Institute conducts biological research and develops tools for scientists. Its cellular datasets support work on disease biology and computational models.

21 open roles+1 this week

Formation Bio

Formation Bio

New York, US · Series D

Formation Bio acquires clinical-stage drugs from pharmaceutical and biotech companies and develops them faster using a proprietary tech-driven platform. The company is building an AI-native platform that integrates biomedical data to guide asset selection, accelerate development, and optimize clinical trial execution.

19 open roleshiring

Vaxcyte

Vaxcyte

Vaxcyte uses its licensed cell-free protein synthesis platform to make vaccines.

18 open roles+2 this week

PacBio

PacBio

Menlo Park, US · Post Ipo

PacBio develops and manufactures DNA sequencing systems for scientists and clinical researchers. Its long-read sequencing technology helps them study complex genetic questions.

17 open roleshiring

Beam Therapeutics

Beam Therapeutics

Beam Therapeutics develops precision genetic medicines through base editing. Its base editing technology is designed to make single base changes without double-stranded DNA breaks.

17 open roles+2 this week

Generate Biomedicines

Generate Biomedicines

Somerville, US · Post Ipo

Generate Biomedicines is a clinical-stage biotherapeutics company pioneering a machine-learning-powered generative biology platform. The Generate Platform can create medicines on demand across multiple therapeutic modalities with unprecedented speed and success rates.

16 open roles+2 this week

Nautilus Biotechnology

Nautilus Biotechnology

Seattle, US · Post Ipo

Nautilus Biotechnology develops a single-molecule proteome analysis platform that uses Iterative Mapping to generate digital counts of proteins and proteoforms in biological samples. The company offers an integrated system of instruments, reagents, and software designed for broad proteome coverage and reproducible quantitative data to support drug development, biomarker discovery, and exploratory biological studies.

16 open roles+1 this week

Ginkgo Bioworks

Ginkgo Bioworks

Boston, US · Post Ipo

Ginkgo Bioworks is building a platform to enable customers to program cells as easily as we can program computers. The company provides autonomous labs that replace manual benchwork, letting scientists order experimental work from robots.

15 open roleshiring

Dyne Therapeutics

Dyne Therapeutics

Dyne Therapeutics develops therapeutics that target muscle and the central nervous system.

13 open roleshiring

REGENXBIO

REGENXBIO

Rockville, US

REGENXBIO advances one-time treatments. Its pipeline targets rare and retinal diseases.

13 open roles+2 this week

Stoke Therapeutics

Stoke Therapeutics

Stoke develops RNA medicines to restore protein expression. TANGO is its proprietary research platform.

12 open roles+3 this week

Radical Numerics

Radical Numerics

San Francisco, US · Seed

Radical Numerics is an AI research lab building general biological intelligence. Its team created Evo and Evo 2, generative genomics models used to create real gene-editing tools and the first whole genomes designed entirely by AI.

12 open roles+1 this week

Insitro

Insitro

South San Francisco, US · Series C

Insitro is a drug discovery and development company using machine learning and data at scale to decode biology for transformative medicines. Its platform generates multi-modal cellular data and high-content phenotypic human cohort data to develop ML-driven predictive disease models.

12 open roles+1 this week

Illumina, Inc.

Illumina, Inc.

San Diego, US · Post Ipo

Illumina sells sequencing and array technologies for life-science research, genomics, and molecular diagnostics.

12 open roles+1 this week

Recursion

Recursion

Salt Lake City, US · Post Ipo

Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system.

11 open roles+1 this week

Owkin

Owkin

Paris, FR

Owkin is an agentic AI company that builds K Pro, an AI scientist for pharmaceutical research and strategic decision-making. K Pro orchestrates a suite of AI skills and tools to decode complex biology and accelerate research.

11 open roles+1 this week

Karius

Karius

Redwood City, US

Karius is a life science, venture-backed clinical metagenomics company focused on elevating patient care through microbial insights. The company's test detects microbial cell-free DNA circulating in the body to assist physicians in making rapid treatment decisions for infectious diseases.

11 open roles+2 this week

Ultima Genomics

Ultima Genomics

Newark, US · Series A

Ultima Genomics is a developer of a low-cost sequencing platform.

11 open roles+4 this week

4D Molecular Therapeutics

4D Molecular Therapeutics

Emeryville, US · Post Ipo

4D Molecular Therapeutics is a late-stage biotechnology company advancing durable and disease-targeted therapeutics. Its lead product candidate 4D-150 is designed to treat blinding retinal vascular diseases with a single intravitreal injection. Its second product candidate 4D-710 is the first known genetic medicine to demonstrate successful delivery and expression of the CFTR transgene in the lungs of people with cystic fibrosis after aerosol delivery.

10 open roles+3 this week

AbCellera

AbCellera

AbCellera discovers and develops antibody-based medicines. Its T-cell engager platform develops multispecific antibodies for difficult-to-treat cancers.

9 open roles+1 this week

Lexeo Therapeutics

Lexeo Therapeutics

Lexeo Therapeutics develops treatments for cardiovascular diseases. Its strategy focuses on therapeutic candidates for cardiovascular and neurological diseases.

9 open roles+2 this week

CRISPR Therapeutics

CRISPR Therapeutics

Zug, CH · Post Ipo

The company achieved a historic milestone with the approval of CASGEVY (exagamglogene autotemcel), the world's first CRISPR-based therapy, for eligible patients with sickle cell disease and transfusion-dependent beta thalassemia. CRISPR Therapeutics is advancing a broad pipeline across hemoglobinopathies, oncology, cardiovascular, autoimmune, regenerative medicine, and rare diseases.

8 open roleshiring

Relay Therapeutics

Relay Therapeutics

Cambridge, US · Post Ipo

Precision breast cancer therapies

8 open roles+1 this week

Latent Labs

Latent Labs

London, GB · Series A

Latent Labs builds AI foundation models to make biology programmable. It enables biotech and pharmaceutical companies to generate and optimize proteins.

8 open roleshiring

Asimov

Asimov

Boston, US · Series B

Asimov develops a mammalian synthetic biology platform to design and manufacture next-generation therapeutics.

7 open roleshiring

Ansa Biotechnologies

Ansa Biotechnologies

Emeryville, US · Series B

The company offers complex DNA synthesis products including clonal DNA up to 50 kb and linear double-stranded DNA fragments.

7 open roles+1 this week

Kriya Therapeutics

Kriya Therapeutics

Series D

Kriya Therapeutics develops gene therapies. Its therapies target common chronic diseases.

7 open roleshiring

Orca Bio

Orca Bio

Menlo Park, US · Series F

Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of blood cancer and autoimmune diseases. Its manufacturing platform uses single-cell precision to create personalized cell therapy products intended to replace a patient's diseased blood and immune system with a healthy one.

7 open roleshiring

Sail Biomedicines

Sail Biomedicines

Sail Biomedicines develops RNA medicines that instruct therapeutic activity inside selected cells.

7 open roleshiring

Octant Bio

Octant Bio

Octant Bio develops small molecules to treat protein misfolding and mistrafficking diseases.

6 open roles+1 this week

Enveda Biosciences

Enveda Biosciences

Boulder, US · Series D

The Company builds a large library of plant-derived molecules and uses AI to discover novel small molecule therapeutics from natural sources. Enveda Biosciences, Inc. develops biotechnology solutions for pharmaceutical drug discovery.

6 open roles+1 this week

GenBio AI

GenBio AI

GenBio AI develops AI models to simulate biological systems. Its models support drug discovery and biomedical research.

6 open roleshiring

Pandorum Technologies

Pandorum Technologies

Series B

Pandorum Technologies develops functional human tissues for medical research and therapeutic applications. It develops cell-free treatments for tissue damage caused by inflammation and fibrosis.

6 open roleshiring

Gordian Biotechnology

Gordian Biotechnology

Gordian Biotechnology starts drug discovery in animals that represent human patients.

6 open roles+1 this week

Superluminal Medicines

Superluminal Medicines

Series B

Superluminal Medicines integrates structural biology with proprietary machine learning tools.

6 open roleshiring

Personalis

Personalis

Fremont, US · Post Ipo

Personalis provides genomic sequencing and analytics solutions for developing vaccines to treat cancers. The company develops end-to-end solutions for immuno-oncology through its Immunoid NeXT Platform.

5 open roles+1 this week

ProQR Therapeutics

ProQR Therapeutics

ProQR Therapeutics develops RNA therapies. Its scientists invented a way to alter RNA with RNA oligonucleotides.

5 open roleshiring

Strand Therapeutics

Strand Therapeutics

Boston, US · Series B

Strand Therapeutics is a clinical-stage biotechnology company pioneering programmable mRNA therapeutics. Its proprietary Signal Stack platform integrates EverScript circular RNA, AmpliScript self-replicating RNA, SignalPath targeted delivery, and logic-driven SignalLock genetic circuits. The company is advancing a pipeline with an initial focus on oncology and autoimmune disease.

5 open roles+3 this week

Tropic

Tropic

Series C

Tropic uses CRISPR gene editing to improve delayed ripening in bananas.

5 open roleshiring

Retro Biosciences

Retro Biosciences

Redwood City, US

Retro Biosciences develops therapies that meaningfully reverse age-related diseases. The company focuses on cellular reprogramming and autophagy to rejuvenate cell and tissue function.

5 open roleshiring

Umoja Biopharma

Umoja Biopharma

Series C

Umoja Biopharma develops in vivo CAR T cell therapies. Its VivoVec platform generates CAR T cells directly inside the patient.

5 open roles+1 this week

Pivot Bio

Pivot Bio

Berkeley, US · Series D

Pivot Bio is a sustainable agriculture company delivering farmers patented crop nutrition technologies that harness the power of nature to reliably and productively grow food. Its proprietary ON Technology harnesses naturally occurring microbes to provide more nutrients to crops, enabling microbes to fix and supply more nitrogen to corn.

5 open roles+1 this week

MeiraGTx

MeiraGTx

MeiraGTx develops viral vectors using capsids, promoters and translational control elements. Its pipeline has end-to-end in-house manufacturing.

5 open roleshiring

Prime Medicine

Prime Medicine

Cambridge, US · Post Ipo

Prime Medicine is a biotechnology company that uses Prime Editing, a next-generation gene editing technology, to develop one-time curative genetic therapies.

5 open roles+1 this week

Krystal Biotech

Krystal Biotech

Pittsburgh, US

Krystal Biotech develops genetic medicines for patients with rare diseases. Its pipeline uses its proprietary redosable HSV vector.

5 open roleshiring

Terray Therapeutics

Terray Therapeutics

Monrovia, US · Series B

Terray Therapeutics is a biotechnology company that integrates ultra-high throughput experimentation and generative AI to discover and develop small molecule therapeutics. Its platform, tNova, combines experimentation and computation to improve the speed, cost, and success rate of small molecule drug discovery.

5 open roles+2 this week

A-Alpha Bio

A-Alpha Bio

A-Alpha Bio measures protein-protein binding affinities with AlphaSeq. Its AlphaBind platform predicts binding strength from protein sequence.

5 open roleshiring

Kyverna Therapeutics

Kyverna Therapeutics

Emeryville, US · Post Ipo

Kyverna Therapeutics is a clinical-stage biopharmaceutical company developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell therapy for conditions such as stiff person syndrome and myasthenia gravis.

5 open roleshiring

ElevateBio

ElevateBio

Waltham, US · Series D

ElevateBio is a technology-driven advanced therapy contract development and manufacturing organization (CDMO) powering the creation of life-transforming therapies. The company helps biopharmaceutical partners design, develop, and manufacture therapies from early discovery through commercialization.

4 open roleshiring

Glyphic Biotechnologies

Glyphic Biotechnologies

Series A

Glyphic Biotechnologies, Inc. is developing the first truly de novo high-throughput proteome sequencing technology capable of discriminating all 20 AAs and PTMs accurately with single molecule sensitivity.

4 open roleshiring

landed applies. You interview.

Let landed apply to biotech companies for you

landed applies to jobs like these on each company’s own site, with answers written for the role. 10 free auto-applies, no card.

Frequently asked

Which biotech companies are hiring right now?

125 biotech companies have open roles. The most: AbbVie (1,336), Amgen (1,237), Bms (318), Tempus Labs (103), Benchling (58).

What roles do biotech companies hire for?

Mostly sales & business development, research & science, software engineering.

Where are biotech companies based?

The biggest hubs are San Francisco, Cambridge, South San Francisco, Boston.

More industries